End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,226 KRW | -2.70% | -7.12% | +7.92% |
Business Summary
Number of employees: 22
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug Development Technology Product
90.3
%
| 14,665 | 87.7 % | 23,505 | 90.3 % | +60.28% |
Research Service
6.5
%
| 1,381 | 8.3 % | 1,692 | 6.5 % | +22.49% |
Royalty
3.2
%
| 682 | 4.1 % | 835 | 3.2 % | +22.45% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 16,729 | 100.0 % | 26,033 | 100.0 % | +55.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hun-Sik Wang
CEO | Chief Executive Officer | 52 | 02-07-31 |
Jun-Sang Park
CTO | Chief Tech/Sci/R&D Officer | 52 | 02-07-31 |
Dae-Jong Park
AUD | Comptroller/Controller/Auditor | 51 | 15-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hun-Sik Wang
CEO | Chief Executive Officer | 52 | 02-07-31 |
Jun-Sang Park
CTO | Chief Tech/Sci/R&D Officer | 52 | 02-07-31 |
Jae-Kyung Park
BRD | Director/Board Member | - | - |
Dong-Hwan Kim
BRD | Director/Board Member | 48 | - |
Yong-Beom Kim
BRD | Director/Board Member | 44 | 20-03-29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 76,699,394 | 59,311,466 ( 77.33 %) | 20 ( 0.000026 %) | 77.33 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
GL PHARM TECH CORP. 0.00% | 20 | 0.00% | 20 $ |
Company contact information
GL Pharm Tech Corp.
Unit 714, Jungang Induspia Wing 5 137 Sagimakgol-ro
13202, Seongnam-si
+
http://www.glpt.co.krSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+7.92% | 69.41M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- A204840 Stock
- Company GL Pharm Tech Corp.